Abstract:Background To evaluate the factors affecting the maximum standardized uptake value (SUVmax) of metastatic lymph nodes in different histological types of non-small cell lung cancer (NSCLC) on integrated positron emission tomography and computed tomography (PET-CT). Methods This was a retrospective, single-institution review of 122 patients with pathologically proven NSCLC who had PET-CT scanning at the same center. Lymph node metastases were pathologically confirmed in tissue specimens from surgical patients. Statistical evaluation of PET-CT results was performed on a per-nodal-station basis. Results The tumor SUVmax of squamous cell carcinoma (SCC) (11.0 ± 4.1) was higher than that of adenocarcinoma (AC) (7.4 ± 4.4) (P < 0.01), however, the SUVmax of the metastatic lymph nodes did not differ between the SCC (4.6 ± 3.1) and AC groups(3.6 ± 2.5) (P = 0.221). The SUVmax of metastatic lymph nodes was positively correlated with lymph node size but not with the primary tumor SUVmax, primary tumor size, tumor location and tumor differentiation. The frequency of a SUVmax of lymph nodes ≥2.5 was 44%, 80%,100% in SCC group and 39%, 59%, 90% in AC group when the short-axis diameter of metastatic lymph node was <10 mm, 10–15 mm, and > 15 mm, respectively. The low sensitivity for metastatic lymph nodes on PET-CT was increased when the SUVmax cut-off for malignancy was considered to be above the normal background compared with that when the SUVmax cut-off was above 2.5. Conclusions There was no difference in the SUVmax of metastatic lymph nodes in the SCC and AC groups. The SUVmax of metastatic lymph nodes was positively correlated with metastatic lymph node size. There was a high false negative rate if lymph nodes with a short-axis diameter less than 10 mm and a extremely low false negative rate if lymph nodes with a short-axis diameter higher than 15 mm. Although an increased sensitivity may be achieved by decreasing the SUVmax cut-off, invasive staging may still be required for negative lymph nodes due to the lower sensitivity of PET-CT in both SCC and AC.

The influencing factors on the accuracy of SUV measurement and their solutions

Issues and countermeasures of the quantitative analysis of standardized uptake value in oncology using positron metabolic imaging with positron emission tomography

Factors affecting liver uptake of 18 F-FDG on PET/CT imaging

Optimizing SUV Analysis: A Multicenter Study on Preclinical FDG-PET/CT Highlights the Impact of Standardization

Relationship Between 18F-FDG Uptake and the Factors Influence the Standardized Uptake Value of Breast Cancer

Analysis of the Common Influencing Factors in the Evaluation of Chemotherapeutic and Radiotherapeutic Efficacy by ~(18)F-FDG PET

The Effect of Standardized Uptake Value of ~(18)F-FDG-PET on Prognosis of Non-small Cell Lung Cancer

Suv Varies With Time In Lung Lesions: The Relationship Between Ri And Biological Influencing Factors

The Value of the Maximum Standardized Uptake Value(SUVmax) of 18F-FDG PET/CT in the Diagnosis for Lung Cancer

Improved identification of tumors in 18F-FDG-PET examination by normalizing the standard uptake in the liver based on blood test data

Challenging the significance of SUV-based parameters in a large-scale retrospective study on lung lesions

Technical Note: Vendor-Specific Approach for Standardized Uptake Value Calculation

Standard uptake value of 18F-FDG in diagnosis of oral squamous cell carcinoma and cervical lymphonode metastatic squamous cell carcinoma

Variations of the liver standardized uptake value in relation to background blood metabolism: An 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography study in a large population from China.

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations

Comparison of PET/CT SUV metrics across different clinical software platforms

Harmonization of Standard Uptake Values Across Different Positron Emission Tomography/computed Tomography Systems and Different Reconstruction Algorithms: Validation in Oncology Patients

Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT

Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018

Variations of the Liver Standardized Uptake Value in Relation to Background Blood Metabolism

Comparison of SUV Between TrueX and OSEM in Oncological Patients